Home
About
The Themis Story
About Us
The Themis Group
Our Milestones
Certifications
From The CEO’s Desk
The Board
The Management Committees
Our Presence
Domestic
International
Business Partners
Our Products
Formulations
API
Products
APIs
Innovations
R&D Breakthroughs
Product In Pipeline
Our Inventions
Manufacturing
Plant Information
QA & RA
EHS Support
Media
Events
News & Announcement
Social Responsibility
Careers
Contact
Head Office
Manufacturing Facilities
Plant Information
Hyderabad
Haridwar
Vapi
Artemis Biotech
(A Division of Themis Medicare Limited)
Plot No. 1 & 5, IDA, Jeedimetla,
Hyderabad - 500 055.
+91.040.2309 5293
/
2309 5294
info@themismedicare.com
Plant Overview
Organization was taken over from
"Andhra Citrates Ltd."
in the Year 1985 and named as
"Artemis Biotech"
.
"Artemis Biotech"
was merged with
"Themis Medicare Limited"
in April 2003
Facility has been in the process of continual up-gradation to make it up to the mark as per the current Good Manufacturing Practices requirement.
Facility Overview
Facility /Area
Area in (Sq.mt)
Production
5160
Warehouse
1080
QA/QC
360
Effluent Treatment Plant, Utilities (Purified water, Boiler, Cooling Towers and HVAC) Maintenance and Administration
3090
Total area of the Plot
16000
Built up area
9690
Products
Simvastatin (Ph. Eur. USP, JP, IP)
No cytotoxic, high potency drugs, beta lactum, penicillin or GMO products are manufactured at this site.
Production Capacity
6.0 Tons
Certifications
CDSCO Certification, India
GMP Certification
ISO Certification 9001 : 2015
GMP Certification, Italy
Attestation of Inspection
M/s. Themis Medicare Ltd.
Sector 6-A, Plot No. 16, 17 & 18,
IIE, BHEL, Haridwar
+91.22.6760 7080
info@themismedicare.com
Plant Overview
The Company is engaged in own and contract manufacturing of pharmaceutical formulations for different Indian customers for distribution in India or other semi regulated markets.
The company shall undertake contract manufacturing of already granted product license/Market Authorization of PL/MA holders.
Focuses on therapeutic segments like cardiology, pain management, anti-tuberculosis, anti-malarial, anti-infective, haemostatics.
Manufacturing facility is constructed in reinforced cement concrete (RCC) with RCC slab roof over all manufacturing areas.
The flooring in the manufacturing areas is finished with Epoxy coating & all walls in the manufacturing area are constructed with clean room partitions & doors.
The ceiling in manufacturing areas is either ferroconcrete plastered to smoothness or paneled with washable emulsion paint.
Modular panels are provided as internal partitions
Facility /Area
Area in (Sq.mt)
Production
4189
Warehouse
780
QA/QC
415
Effluent Treatment Plant, Utilities (Purified water, Boiler, Cooling Towers and HVAC)
345
Maintenance and Administration
415
Total area of the Plot
13420
Manufacturing Capacity
Production Section
SVP (Vial & Amp)
General Tablet
Ointment/Cream /Gel
Rifampicin Tablet
Certifications
ISO 13485 - 2016
EU GMP Certificate
Philippines FDA
M/s. Themis Medicare Ltd.
69 / A, GIDC Industrial Estate,
Vapi, Dist. Valsad, Gujarat 396 195
+91.22.6760 7080
info@themismedicare.com
Facility Overview
Facility /Area
Area in (Sq.mt)
Production
9237.87
Warehouse
458.64
QA/QC
179.47
Effluent Treatment Plant, Utilities (Purified water, Boiler, Cooling Towers and HVAC)
114.32
Maintenance and Administration
488.05
Home
Manufacturing
Plant Information